Annual EBITDA
$15.18 M
+$33.95 M+180.85%
December 31, 2023
Summary
- As of February 12, 2025, NARI annual EBITDA is $15.18 million, with the most recent change of +$33.95 million (+180.85%) on December 31, 2023.
- During the last 3 years, NARI annual EBITDA has fallen by -$1.13 million (-6.94%).
- NARI annual EBITDA is now -6.94% below its all-time high of $16.31 million, reached on December 31, 2020.
Performance
NARI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$7.21 M
+$9.40 M+56.59%
September 30, 2024
Summary
- As of February 12, 2025, NARI quarterly EBITDA is -$7.21 million, with the most recent change of +$9.40 million (+56.59%) on September 30, 2024.
- Over the past year, NARI quarterly EBITDA has increased by +$9.40 million (+56.59%).
- NARI quarterly EBITDA is now -184.56% below its all-time high of $8.53 million, reached on March 31, 2021.
Performance
NARI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$34.87 M
-$15.02 M-75.64%
September 30, 2024
Summary
- As of February 12, 2025, NARI TTM EBITDA is -$34.87 million, with the most recent change of -$15.02 million (-75.64%) on September 30, 2024.
- Over the past year, NARI TTM EBITDA has dropped by -$15.02 million (-75.64%).
- NARI TTM EBITDA is now -223.82% below its all-time high of $28.16 million, reached on June 30, 2021.
Performance
NARI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
NARI EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +180.8% | +56.6% | -75.6% |
| 3 y3 years | -6.9% | -331.7% | -279.9% |
| 5 y5 years | +268.9% | -1063.9% | -10000.0% |
NARI EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | +180.8% | -192.4% | +56.6% | -328.1% | at low |
| 5 y | 5-year | -6.9% | +180.8% | -184.6% | +56.6% | -223.8% | at low |
| alltime | all time | -6.9% | +180.8% | -184.6% | +56.6% | -223.8% | at low |
Inari Medical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.21 M(-56.6%) | -$34.87 M(+75.6%) |
| Jun 2024 | - | -$16.61 M(+45.8%) | -$19.85 M(-1110.2%) |
| Mar 2024 | - | -$11.39 M(-3402.3%) | $1.97 M(-87.1%) |
| Dec 2023 | $15.18 M(-180.8%) | $345.00 K(-95.6%) | $15.18 M(+26.6%) |
| Sep 2023 | - | $7.80 M(+49.9%) | $11.99 M(-462.0%) |
| Jun 2023 | - | $5.21 M(+186.3%) | -$3.31 M(-78.7%) |
| Mar 2023 | - | $1.82 M(-164.0%) | -$15.56 M(-17.1%) |
| Dec 2022 | -$18.77 M(-222.8%) | -$2.84 M(-62.1%) | -$18.77 M(+50.1%) |
| Sep 2022 | - | -$7.50 M(+6.4%) | -$12.51 M(+87.1%) |
| Jun 2022 | - | -$7.04 M(+407.1%) | -$6.68 M(-224.4%) |
| Mar 2022 | - | -$1.39 M(-140.6%) | $5.37 M(-64.9%) |
| Dec 2021 | $15.29 M | $3.42 M(-304.7%) | $15.29 M(-21.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$1.67 M(-133.3%) | $19.38 M(-31.2%) |
| Jun 2021 | - | $5.01 M(-41.2%) | $28.16 M(+40.1%) |
| Mar 2021 | - | $8.53 M(+13.5%) | $20.10 M(+23.3%) |
| Dec 2020 | $16.31 M(+4668.7%) | $7.51 M(+5.8%) | $16.31 M(+69.6%) |
| Sep 2020 | - | $7.11 M(-333.6%) | $9.62 M(+194.9%) |
| Jun 2020 | - | -$3.04 M(-164.3%) | $3.26 M(-42.6%) |
| Mar 2020 | - | $4.73 M(+475.0%) | $5.68 M(+1563.8%) |
| Dec 2019 | $342.00 K(-103.8%) | $823.00 K(+10.0%) | $341.60 K(-171.0%) |
| Sep 2019 | - | $748.00 K(-220.7%) | -$481.40 K(-60.8%) |
| Jun 2019 | - | -$619.50 K(+1.6%) | -$1.23 M(+101.6%) |
| Mar 2019 | - | -$609.90 K | -$609.90 K |
| Dec 2018 | -$8.98 M | - | - |
FAQ
- What is Inari Medical annual EBITDA?
- What is the all time high annual EBITDA for Inari Medical?
- What is Inari Medical annual EBITDA year-on-year change?
- What is Inari Medical quarterly EBITDA?
- What is the all time high quarterly EBITDA for Inari Medical?
- What is Inari Medical quarterly EBITDA year-on-year change?
- What is Inari Medical TTM EBITDA?
- What is the all time high TTM EBITDA for Inari Medical?
- What is Inari Medical TTM EBITDA year-on-year change?
What is Inari Medical annual EBITDA?
The current annual EBITDA of NARI is $15.18 M
What is the all time high annual EBITDA for Inari Medical?
Inari Medical all-time high annual EBITDA is $16.31 M
What is Inari Medical annual EBITDA year-on-year change?
Over the past year, NARI annual EBITDA has changed by +$33.95 M (+180.85%)
What is Inari Medical quarterly EBITDA?
The current quarterly EBITDA of NARI is -$7.21 M
What is the all time high quarterly EBITDA for Inari Medical?
Inari Medical all-time high quarterly EBITDA is $8.53 M
What is Inari Medical quarterly EBITDA year-on-year change?
Over the past year, NARI quarterly EBITDA has changed by +$9.40 M (+56.59%)
What is Inari Medical TTM EBITDA?
The current TTM EBITDA of NARI is -$34.87 M
What is the all time high TTM EBITDA for Inari Medical?
Inari Medical all-time high TTM EBITDA is $28.16 M
What is Inari Medical TTM EBITDA year-on-year change?
Over the past year, NARI TTM EBITDA has changed by -$15.02 M (-75.64%)